BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maccaroni E, Giampieri R, Lenci E, Scortichini L, Bianchi F, Belvederesi L, Brugiati C, Pagliaretta S, Ambrosini E, Berardi R. BRCA mutations and gastrointestinal cancers: When to expect the unexpected? World J Clin Oncol 2021; 12(7): 565-580 [PMID: 34367929 DOI: 10.5306/wjco.v12.i7.565]
URL: https://www.wjgnet.com/2218-4333/full/v12/i7/565.htm
Number Citing Articles
1
Gulnur Zhunussova, Nazgul Omarbayeva, Dilyara Kaidarova, Saltanat Abdikerim, Natalya Mit, Ilya Kisselev, Kanagat Yergali, Aigul Zhunussova, Tatyana Goncharova, Aliya Abdrakhmanova, Leyla Djansugurova. Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicityOncotarget 2023; 14(1): 860 doi: 10.18632/oncotarget.28518
2
Evgeny N Imyanitov, Ekaterina S Kuligina, Anna P Sokolenko, Evgeny N Suspitsin, Grigoriy A Yanus, Aglaya G Iyevleva, Alexandr O Ivantsov, Svetlana N Aleksakhina. Hereditary cancer syndromesWorld Journal of Clinical Oncology 2023; 14(2): 40-68 doi: 10.5306/wjco.v14.i2.40
3
Gyongyver Szentmartoni, Dorottya Mühl, Renata Csanda, Attila Marcell Szasz, Zoltan Herold, Magdolna Dank. Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid TumorsBiomedicines 2024; 12(3): 593 doi: 10.3390/biomedicines12030593
4
Yi‐Ru Bai, Wei‐Guang Yang, Rui Jia, Ju‐Shan Sun, Dan‐Dan Shen, Hong‐Min Liu, Shuo Yuan. The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancerMedicinal Research Reviews 2025; 45(1): 214 doi: 10.1002/med.22069
5
Fatemeh Ghorbani Parsa, Stefania Nobili, Mina Karimpour, Hamid Asadzadeh Aghdaei, Ehsan Nazemalhosseini-Mojarad, Enrico Mini. Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and TherapyJournal of Personalized Medicine 2022; 12(3): 396 doi: 10.3390/jpm12030396
6
Precise, Genotype-First Breast Cancer Prevention: Experience With Transferring Monogenic Findings From a Population Biobank to the Clinical SettingFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.881100
7
T. V. Schäfer, O. A. Vakunenkova, K. V. Firsov, Ju. Ju. Ivnitsky. Self-Destructive Behavior among Predictors of Cancer IncidenceBiology Bulletin Reviews 2022; 12(6): 638 doi: 10.1134/S2079086422060081
8
Marwa Mohammed Ali Jassim, Shaymaa A. Naji, Majid Mohammed Mahmood. BRCA1, BCL2, and the RB Tumor Suppressor have abnormal expressions in lung cancerResearch Journal of Pharmacy and Technology 2022; : 4083 doi: 10.52711/0974-360X.2022.00685
9
Kaler Amrit Kaur, Upadhyay Shraddha Manoj , Bora Nandini Shyamali , Nikam Ankita , P Kavya , Athikeri Nivetha , Solanki Dattatray B , Shaikh Imran , Mistry Rajesh . Germline BRCA1 Mutation inSquamous Cell Carcinoma of Oesophagus: Driver versus Passenger MutationJournal of Genetic Medicine and Gene Therapy 2024; 7(1): 015 doi: 10.29328/journal.jgmgt.1001011
10
Sabastain F Forsah, Sini Bijoy, Divine Besong Arrey Agbor, Derek Ugwendum, Margarieta Okang, Uroosa M Syed, Cinthya Aviles, Jay Nfonoyim. Metastatic Early-Onset Colon Cancer With BRCA2 Mutation Presenting With a Large Obstructing Pelvic Mass and Causing Acute Liver Failure and Acute Hypoxic Respiratory FailureCureus 2024;  doi: 10.7759/cureus.64770
11
Airat Bilyalov, Sergey Nikolaev, Anastasiia Danishevich, Igor Khatkov, Komron Makhmudov, Zhainagul Isakova, Nurbek Bakirov, Ernis Omurbaev, Alena Osipova, Ramaldan Ramaldanov, Elena Shagimardanova, Andrey Kiyasov, Oleg Gusev, Natalia Bodunova. The Spectrum of Germline Nucleotide Variants in Gastric Cancer Patients in the Kyrgyz RepublicCurrent Issues in Molecular Biology 2023; 45(8): 6383 doi: 10.3390/cimb45080403
12
Shadin Ghabra, Andrew M. Blakely, Andrew Mannes, Ning Miao. Anesthesia for Oncological Surgery2023; : 279 doi: 10.1007/978-3-031-50977-3_42
13
Muxing Kang, Xiaojing Ma, Jifei Shi, Guofeng Chen, Xiaoli Jin, Jun Wang, Lele Lin, Zhiwei Wu, Kaibo Chen, Jinghong Xu, Pintong Huang, Jian Chen. Distinct molecular phenotype and the potential prognostic value of immune prognostic index and tumor infiltrating lymphocytes in hepatoid adenocarcinoma of stomachTranslational Oncology 2022; 19: 101380 doi: 10.1016/j.tranon.2022.101380
14
Anant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, Anuj Gupta, Akhil Kapoor, Sujay Srinivas, Omshree Shetty, Poonam Jadhav, Veena Desai, Vanita Noronha, Amit Joshi, Nandini Menon, Vijay M Patil, Bal Krishna Mishra, Bipinesh Sansar, Arpita Singh, Swapnil Patel, Satyendra Narayan Singh, Ipsita Dhal, Kunal Ranjan Vinayak, Vikash Pal, Sarika Mandavkar, Sadhana Kannan, Deepali Chaugule, Rajshree Patil, Manali Parulekar, Chaitali Nashikkar, Suman Kumar Ankathi, Rajiv Kumar Kaushal, Aekta Shah, Prasanth Ganesan, Smita Kayal, Ramesh Ananthakrishnan, Noorzia Syed, Debdeep Samaddar, Venkatesh Kapu, Anokhi Shah, D Kaaviya, R Suganiya, Nirmala Devi Srinivasan, Kumar Prabhash, Vikas Ostwal. Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancersJNCI Cancer Spectrum 2024; 8(4) doi: 10.1093/jncics/pkae054